Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Autoimmune Disorders

  Free Subscription


Articles published in Thyroid

Retrieve available abstracts of 32 articles:
HTML format
Text format



Single Articles


    May 2017
  1. GIESECKE P, Rosenqvist M, Frykman V, Friberg L, et al
    Increased Cardiovascular Mortality and Morbidity in Patients Treated for Toxic Nodular Goiter Compared to Graves' Disease and Nontoxic Goiter.
    Thyroid. 2017 May 4. doi: 10.1089/thy.2017.0029.
    PubMed     Text format     Abstract available


    April 2017
  2. RUBIO GA, Koru-Sengul T, Vaghaiwalla TM, Parikh PP, et al
    Postoperative Outcomes in Graves' Disease Patients: Results from the Nationwide Inpatient Sample Database.
    Thyroid. 2017 Apr 29. doi: 10.1089/thy.2016.0500.
    PubMed     Text format     Abstract available


  3. LIU T, Sun J, Wang Z, Yang W, et al
    Changes in the DNA methylation and hydroxymethylation status of the intercellular adhesion molecule 1 gene promoter in thyrocytes from autoimmune thyroiditis patients.
    Thyroid. 2017 Apr 7. doi: 10.1089/thy.2016.0576.
    PubMed     Text format     Abstract available


    March 2017
  4. LI C, Peng S, Liu X, Han C, et al
    Glycyrrhizin, a direct HMGB1 antagonist, ameliorates inflammatory infiltration in a model of autoimmune thyroiditis via inhibition of TLR2-HMGB1 signaling.
    Thyroid. 2017 Mar 31. doi: 10.1089/thy.2016.0432.
    PubMed     Text format     Abstract available


  5. HU S, Rayman MP
    Multiple nutritional factors and the risk of Hashimoto's Thyroiditis.
    Thyroid. 2017 Mar 14. doi: 10.1089/thy.2016.0635.
    PubMed     Text format     Abstract available


    January 2017
  6. ZAGHLOL R, Haghighi A, Alkhayyat M, Farhan O, et al
    Consanguinity and the risk of Hashimoto's Thyroiditis.
    Thyroid. 2017 Jan 6. doi: 10.1089/thy.2016.0495.
    PubMed     Text format     Abstract available


    November 2016
  7. ROTONDO DOTTORE G, Leo M, Casini G, Latrofa F, et al
    ANTI-OXIDANT ACTIONS OF SELENIUM IN ORBITAL FIBROBLASTS: A BASIS FOR THE EFFECTS OF SELENIUM IN GRAVES' ORBITOPATHY.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    October 2016
  8. MALHOTRA S, Heptulla RA, Homel P, Motaghedi R, et al
    Effect of marijuana use on thyroid function and autoimmunity.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  9. HATTORI N, Ishihara T, Matsuoka N, Saito T, et al
    Anti-TSH autoantibodies in patients with macro-TSH and long-term changes in macro-TSH and serum TSH levels.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  10. FUJII A, Inoue N, Watanabe M, Kawakami C, et al
    <i>TSHR</i>genepolymorphisms intheenhancerregions are most strongly associatedwiththe development of Graves' disease, especially intractable disease, and with that of Hashimoto's disease.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  11. WICHMAN J, Winther KH, Bonnema SJ, Hegedus L, et al
    Selenium supplementation significantly reduces thyroid autoantibody levels in patients with chronic autoimmune thyroiditis: A systematic review and meta-analysis.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    September 2016
  12. HIRATSUKA I, Yamada H, Munetsuna E, Hashimoto S, et al
    Circulating microRNAs in Graves' Disease in Relation to Clinical Activity.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    August 2016
  13. AVERSA T, Corrias A, Salerno M, Tessaris D, et al
    Five-year prospective evaluation of thyroid function test evolution in children with Hashimoto's thyroiditis presenting with either euthyroidism or subclinical hypothyroidism.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    July 2016
  14. CHNG CL, Lim AY, Tan HC, Kovalik JP, et al
    Physiological and metabolic changes during the transition from hyperthyroidism to euthyroidism in Graves' disease.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    June 2016
  15. WERION A, Joris V, Hepp M, Papasokrati L, et al
    Pioglitazone, a PPARgamma agonist, upregulates the expression of caveolin-1 and catalase, essential for thyroid cell homeostasis. A clue to the pathogenesis of Hashimoto's thyroiditis.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  16. SHARMA R, Di Dalmazi G, Caturegli P Dr
    Exacerbation of Autoimmune Thyroiditis by CTLA-4 blockade: a role for IFNgamma-induced indoleamine 2, 3-dioxygenase.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  17. BRITO JP, Schilz S, Singh Ospina NM, Rodriguez-Gutierrez R, et al
    Antithyroid Drugs- the most common treatment for Graves' disease in the United States: a nationwide population-based study.
    Thyroid. 2016.
    PubMed     Text format    


  18. PANI F, Atzori F, Baghino G, Boi F, et al
    HYPOTHYROIDISM AND THYROID AUTOIMMUNITY AS A PROGNOSTIC BIOMARKER OF BETTER RESPONSE IN METASTATIC CANCER LONG SURVIVORS TREATED WITH SUNITINIB.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  19. TUN NN, Beckett G, Zammitt N, Strachan MW, et al
    Thyrotropin receptor antibody levels at diagnosis and after thionamide course predict Graves' disease relapse.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  20. ROY A, Laszkowska M, Sundstrom J, Lebwohl B, et al
    Prevalence of celiac disease in patients with autoimmune thyroid disease - a meta-analysis.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    April 2016
  21. ZHYZHNEUSKAYA S, Addison C, Tsatlidis V, Weaver IU, et al
    The natural history of subclinical hyperthyroidism in Graves' disease - the rule of thirds.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  22. BARBESINO G
    Misdiagnosis of Graves' disease with apparent severe hyperthyroidism in a patient taking biotin megadoses.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    March 2016
  23. LATROFA F, Ricci D, Sisti E, Piaggi P, et al
    Significance of low levels of thyroglobulin autoantibodies associated with undetectable thyroglobulin after thyroidectomy for differentiated thyroid carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  24. STRUJA TM, Guebelin L, Kutz A, Fehlberg H, et al
    Does Immunosuppressive Therapy Improve Outcomes in Graves' disease? A Systematic Review and Meta-analysis.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    February 2016
  25. DONNELLY PE, Winch DE, Pollard J
    Thyroid Steal - Surgery for Graves' disease a Century ago.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  26. RUGGERI RM, Vicchio TM, Cristani M, Certo R, et al
    OXIDATIVE STRESS AND ADVANCED GLYCATION END PRODUCTS (AGEs) IN HASHIMOTO'S THYROIDITIS.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    January 2016
  27. LIU L, Wu L, Gao A, Zhang Q, et al
    The influence of dihydrotestosterone on the development of Graves' disease in female BALB/c mice.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    December 2015
  28. BJERGVED L, Carle A, Jorgensen T, Perrild H, et al
    Parity and 11-year serum thyrotropin and thyroid autoantibody change: A longitudinal population-based study.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    August 2015
  29. PONTO KA, Binder H, Diana T, Matheis N, et al
    Prevalence, Phenotype, and Psychosocial Well-Being in Euthyroid/Hypothyroid Thyroid-Associated Orbitopathy.
    Thyroid. 2015;25:942-8.
    PubMed     Text format     Abstract available


    July 2015
  30. KUMAR S, Coenen MJ, Iyer S, Bahn RS, et al
    The forkhead transcription factor Fox01 is regulated by both a stimulatory thyrotropin receptor antibody and insulin-like growth factor-1 in orbital fibroblasts from patients with Graves' ophthalmopathy.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    April 2015
  31. TOHMA Y, Akturk M, Altinova AE, Yassibas E, et al
    Circulating Levels of Orexin-A, Nesfatin-1, Agouti Related Peptide, and Neuropeptide Y in Patients with Hyperthyroidism.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    March 2015
  32. YANG J, Li LF, Xu Q, Zhang J, et al
    Analysis of 90 cases of antithyroid drug-induced severe hepatotoxicity over 13 years in China.
    Thyroid. 2015;25:278-83.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: